Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Reports add new data to cervical cancer research
February 2nd, 2006
Data on cervical cancer are outlined in reports from Japan, the Czech Republic and Wales. Study 1: Human papillomavirus 16-E6 protein-derived peptides generate cytotoxic T lymphocytes toward HLA-A241 cervical cancer. "Human papillomavirus 16 (HPV16)-E6 and -E7 proteins are considered to be appropriate targets in specific immunotherapy for cervical cancer. In this study, we attempted to identify epitope peptides from the HPV16-E6 protein that have the potential to generate cytotoxic T-lymphocytes (CTLs) toward human leukocyte antigen (HLA)-A24+ cervical cancer," investigators in Japan report. "Two HPV16-E6 peptides at positions...
Source: Women's Health Weekly (2006-02-02)
|
